Ambulatory Surgery Center Direct Market Analysis

Nerve Blocks Market to Reach USD 9.4 Billion by 2033 at 6.4% CAGR

ASCs increasingly bypass traditional hospital GPO channels to negotiate direct supply agreements with pharmaceutical and device manufacturers, leveraging high-volume single-procedure concentrations to achieve favorable pricing. This channel is growing fastest as ASC procedure volumes expand under CMS policy. 503B outsourcing facility supply is particularly important in this channel, as ASCs have greater flexibility than hospitals to use compounded preparations and less exposure to Joint Commission oversight.